PWE-043 The UK Multicentre Audit of Management and Outcome of Autoimmune Hepatitis (AIH). Prednisolone or Budesonide (or Neither) – and for How Long? | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Citation Tools

BSG 2016

PWE-043 The UK Multicentre Audit of Management and Outcome of Autoimmune Hepatitis (AIH). Prednisolone or Budesonide (or Neither) – and for How Long?

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Gordon V, on behalf of UK Autoimmune Hepatitis Audit Group

PWE-043 The UK Multicentre Audit of Management and Outcome of Autoimmune Hepatitis (AIH). Prednisolone or Budesonide (or Neither) – and for How Long?

Gut 2016;65:A160.